AIDS

1. TODESCO E, Valantin MA, Akhavan S, Rouget R, et al
   Acute hepatitis B infections among PWH treated with 2-drug regimen: can we trust the vaccination status?
   AIDS. 2025;39:1845-1847.
   

   >> Share

   
   

   
   Eur J Gastroenterol Hepatol

2. CHON YE, Lee J, Yoon EL, Kim SS, et al
   Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study.
   Eur J Gastroenterol Hepatol. 2025;37:1166-1172.
   

   >> Share

   
   

   
   J Hepatol

3. DALEKOS GN, Gatselis N, Tiniakos D
   EASL CPG: Liver biopsy cannot be skipped for the diagnosis of autoimmune hepatitis.
   J Hepatol. 2025 Sep 3:S0168-8278(25)02468-7. doi: 10.1016/j.jhep.2025.
   

   >> Share

   
   

   
   J Med Virol

4. KIM H, Kim JY, Choi HB, Lee JS, et al
   Antiviral Therapy Reduces Dyslipidemia and Cardiovascular Risk in Chronic Hepatitis B: TDF as the Most Effective Agent.
   J Med Virol. 2025;97:e70584.
   

   >> Share

   
   
5. ZHONG S, Zeng Z, Jin Z, Zhang L, et al
   Single-Cell Profiling of Peripheral and Intrahepatic B Cells Reveals Altered Responses and a CCR7(+) Subset Linked to Antiviral Potential in Chronic HBV Infection.
   J Med Virol. 2025;97:e70572.
   

   >> Share

   
   

   
   J Viral Hepat

6. HANDANAGIC S, Shadaker S, BaliashvilI D, Schumacher IT, et al
   Demographic and Clinical Characteristics of Patients With Hepatitis C and Hepatitis B Co-Infection, Georgia, 2017-2023.
   J Viral Hepat. 2025;32:e70067.
   

   >> Share

   
   
7. HUANG D, Zhu Z, Peng J, Zhang S, et al
   Global Trends and Health Inequalities in Acute Hepatitis E Burden: A Joinpoint Regression and Cross-Country Inequality Analysis, 1990-2021.
   J Viral Hepat. 2025;32:e70073.
   

   >> Share

   
   
8. TORGERSEN J, Smookler D, Russell R, Gasior J, et al
   Early Read-Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV Viremia.
   J Viral Hepat. 2025;32:e70066.
   

   >> Share

   
   
9. KASSA GM, Lim AG, Tamiru MT, Alamneh TS, et al
   Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review Data.
   J Viral Hepat. 2025;32:e70065.
   

   >> Share

   
   

   
   J Virol

10. HAGA Y, Babu E P, Swiderska-Syn M, Reagan EK, et al
    Hepatitis C virus modified (S)E2(F442NYT)-mRNA-LNP candidate vaccine promotes helper CXCR5(+)T cells.
    J Virol. 2025 Sep 5:e0135525. doi: 10.1128/jvi.01355.
    

    >> Share

    
    
11. SCHWOERER MP, Carver S, Cafiero TR, Joyce B, et al
    Assessment of hepatitis C virus permissiveness in iteratively genetically humanized mice.
    J Virol. 2025 Sep 3:e0079325. doi: 10.1128/jvi.00793.
    

    >> Share

    
    

    
    PLoS One

12. SONG J, Choi SJ, Kim S, Park Y, et al
    Comparative evaluation of four fully automated immunoanalyzers for the simultaneous detection of HBeAg and Anti-HBe.
    PLoS One. 2025;20:e0331381.
    

    >> Share

    
    
13. QI X, Hu Y, Jiang W
    Epidemiological trends and projections to 2035 of hepatitis B burden in China, 1990-2021.
    PLoS One. 2025;20:e0330633.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share